Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive?
Tài liệu tham khảo
Waksman, 2000, Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis, Circulation, 101, 1895, 10.1161/01.CIR.101.16.1895
Silber, 2005, Two-year clinical follow-up of 90Sr/90Y beta-radiation versus placebo control for the treatment of in-stent restenosis, Am Heart J, 149, 689, 10.1016/j.ahj.2004.05.061
Rha, 2005, Three-year follow-up after intravascular gamma-radiation for in-stent restenosis in saphenous vein grafts, Catheter Cardiovasc Interv, 65, 257, 10.1002/ccd.20372
Holmes, 2006, Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial, JAMA, 295, 1264, 10.1001/jama.295.11.1264
Stone, 2006, Paclitaxel-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial, JAMA, 295, 1253, 10.1001/jama.295.11.1253
Haase, 2005, Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis, Cardiovasc Revasc Med, 6, 140, 10.1016/j.carrev.2005.09.002
King, 1998, Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the Beta Energy Restenosis Trial (BERT), Circulation, 97, 2025, 10.1161/01.CIR.97.20.2025
Raizner, 1999, The Guidant coronary source wire system, 505
Arjomand, 2003, Percutaneous coronary intervention: historical perspectives, current status and future directions, Am Heart J, 146, 787, 10.1016/S0002-8703(03)00153-4
Nguyen-Ho, 2002, Intracoronary brachytherapy, Catheter Cardiovasc Interv, 56, 281, 10.1002/ccd.10260
Popma, 2002, Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis, Circulation, 106, 1090, 10.1161/01.CIR.0000027814.96651.72
Waksman, 2002, Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial, Lancet, 359, 551, 10.1016/S0140-6736(02)07741-3
Grise, 2002, Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial, Circulation, 105, 2737, 10.1161/01.CIR.0000018126.87045.E0
Waksman, 2004, Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis, Circulation, 109, 340, 10.1161/01.CIR.0000109488.62415.01
Haase, 2003, Long-term outcome after implantation of bare metal stents fort he treatment of coronary artery disease, J Interv Cardiol, 16, 469, 10.1046/j.1540-8183.2003.01059.x
Teirstein, 2000, Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial, Circulation, 101, 360, 10.1161/01.CIR.101.4.360
Chu, 2005, Drug-eluting stets versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation, J Invasive Cardiol, 17, 659
Kaluza, 2004, Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era, Curr Opin Cardiol, 19, 601, 10.1097/01.hco.0000142069.39957.03
Torguson, 2006, Intravascular brachytherapy versus repeat drug-eluting stenting for the treatment of patients with drug-eluting stent restenosis, J Am Coll Cardiol, 47, B43
Colombo, 2006, Drug-eluting stent thrombosis, J Am Coll Cardiol, 48, 203, 10.1016/j.jacc.2006.04.040
Joner, 2006, Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk, J Am Coll Cardiol, 48, 193, 10.1016/j.jacc.2006.03.042